TY - JOUR
T1 - Radiation exposure during standing voiding cystourethrography in women
AU - Arbique, Gary M.
AU - Gilleran, Jason P.
AU - Guild, Jeffrey B.
AU - Harris, Joan E.
AU - Poon, Christine I.
AU - Zimmern, Philippe E.
PY - 2006/2
Y1 - 2006/2
N2 - Objectives. To calculate the total radiation exposure and effective organ doses from standard protocol voiding cystourethrography (VCUG). Methods. A prospective series of consecutive, non-neurogenic women underwent a standardized VCUG protocol by the same technologist using a Siemens Sireskop Fluorospot radiographic/fluoroscopic unit. Only studies that followed the protocol were included. The effective dose was calculated using a commercially available dose-modeling program (PCXMC, version 1.5) for risk assessment. Results. A total of 119 studies in 118 women (mean age 60 ± 13 years, range 30 to 93) were included. Only 15 patients (13%) were premenopausal with in situ reproductive organs. The mean number of images and fluoroscopic time per study was 12.8 ± 1.4 (lateral images 7.5 ± 1.3) and 35.8 ± 11.2 seconds, respectively. The mean effective dose for a single VCUG study was calculated to be 4.3 mSv, of which 26% was from fluoroscopy (1.1 mSv). The dose to the gonads accounted for 50% of the total effective organ dose. Using whole population radiologic risk factors, the total risk detriment, cancer and hereditary, was about 3 per 10,000 patients or a 99.997% chance of no detriment incurred from the study. The genetic and malignant risks were reduced in this cohort of patients, who were older, with most (87%) having no reproductive potential. Conclusions. Using a standard protocol for adult women, a VCUG study is associated with an acceptable radiation risk.
AB - Objectives. To calculate the total radiation exposure and effective organ doses from standard protocol voiding cystourethrography (VCUG). Methods. A prospective series of consecutive, non-neurogenic women underwent a standardized VCUG protocol by the same technologist using a Siemens Sireskop Fluorospot radiographic/fluoroscopic unit. Only studies that followed the protocol were included. The effective dose was calculated using a commercially available dose-modeling program (PCXMC, version 1.5) for risk assessment. Results. A total of 119 studies in 118 women (mean age 60 ± 13 years, range 30 to 93) were included. Only 15 patients (13%) were premenopausal with in situ reproductive organs. The mean number of images and fluoroscopic time per study was 12.8 ± 1.4 (lateral images 7.5 ± 1.3) and 35.8 ± 11.2 seconds, respectively. The mean effective dose for a single VCUG study was calculated to be 4.3 mSv, of which 26% was from fluoroscopy (1.1 mSv). The dose to the gonads accounted for 50% of the total effective organ dose. Using whole population radiologic risk factors, the total risk detriment, cancer and hereditary, was about 3 per 10,000 patients or a 99.997% chance of no detriment incurred from the study. The genetic and malignant risks were reduced in this cohort of patients, who were older, with most (87%) having no reproductive potential. Conclusions. Using a standard protocol for adult women, a VCUG study is associated with an acceptable radiation risk.
UR - http://www.scopus.com/inward/record.url?scp=31944450973&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31944450973&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2005.08.051
DO - 10.1016/j.urology.2005.08.051
M3 - Article
C2 - 16461076
AN - SCOPUS:31944450973
SN - 0090-4295
VL - 67
SP - 269
EP - 274
JO - Urology
JF - Urology
IS - 2
ER -